MaRS, SickKids develop anti-scarring cream with Chinese drug firm
MaRS Innovation and The Hospital for Sick Children, both in Toronto, along with NovoTek Therapeutics Inc. of Beijing, China, have announced a strategic partnership to co-develop and bring to the Chinese market a novel therapeutic cream aimed at reducing scar formation following surgery.